Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The Food and Drug Administration (FDA) reports that some levels of nitrosamine are ok, and frequent in food and drink ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Kezar Life Sciences can’t catch a break this fall with its autoimmune candidate zetomipzomib. Just over a month after the FDA ...

For the most part, you can walk in and out of Walmart without carrying any form of ID. Rarely would you need it, but there are a few specific instances in which it’s necessary: Age restrictions: You ...

SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...

As 2024 ushers in political change, one of the most contentious issues bubbling beneath the surface is public health — notably, the role of addictive substances ...

Last month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward ...

Costco customers with dairy allergies may need to check their fridge due to 80,000 pounds of the retailer's butter being recalled for packaging missing the "Contains Milk statement," according to the ...

GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Signa Magnus MRI scanner.

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...